Pvg Asset Management Corp Aileron Therapeutics Inc Transaction History

Pvg Asset Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.2 - $5.0 $23,520 - $588,000	-117,600 Closed	0 $0
Q3 2022 Oct 13, 2022	BUY	$0.14 - $4.5 $9,422 - $302,850	67,300 Added 133.8%	117,600 $0
Q4 2021 Feb 02, 2022	BUY	$0.52 - $1.06 $13,907 - $28,349	26,745 Added 113.54%	50,300 $28,000
Q3 2021 Nov 10, 2021	BUY	$0.98 - $1.31 $8,379 - $11,200	8,550 Added 56.98%	23,555 $24,000
Q2 2021 Aug 17, 2021	BUY	$1.06 - $1.43 $689 - $929	650 Added 4.53%	15,005 $18,000
Q1 2021 May 14, 2021	BUY	$1.05 - $2.22 $15,072 - $31,868	14,355 New	14,355 $20,000

213

Ticker ALRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,823,600
Market Cap $210M
Description
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advan...

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Pvg Asset Management Corp with notifications on news.